A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung CancerPepinemab in Combination with Avelumab in NSCLC

Overview of attention for article published in Clinical Cancer Research, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Dimensions has found 12 publications that cite this research output.

Article in International Immunopharmacology (April 2024)

Article in Pediatric Blood & Cancer (March 2024)

Article in Frontiers in Immunology (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.